arrow
J

Janessa Laskin

BC Cancer
H指数:44
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trials

将无进展生存比作为精准肿瘤学临床试验的主要终点进行基准测试

2025-12-150
OAAI
mTOR Inhibition in the Management of Recurrent Metastatic Solid Pseudopapillary Tumor of the Pancreas

mTOR抑制剂在复发性转移性胰腺实性假乳头状瘤管理中的应用

2025-12-010
PRE
Cross-platform methylation-based site of origin classification for squamous cell carcinomas

跨平台甲基化基元起源分类用于鳞状细胞癌

2025-09-010
OAAI
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma

多组学全基因组表征转移性胰腺导管腺癌的拷贝数景观

2025-07-220
OA
Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis

中性粒细胞胞外陷阱基因表达特征识别用于抑制胰腺肿瘤转移的预后和可靶向信号轴

2025-07-040
OAAI
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Mitigation of decline with virtual exercise with lung cancer (MoVE with lung cancer) - A promising approach to enhance physiological strength, improve body composition, and build upon current evidence

减轻肺癌患者衰退的虚拟锻炼方案(MoVE with lung cancer)——一种增强生理力量、改善身体成分并基于当前证据的可行方法

2025-03-010
PRE
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study

奥希替尼在参加AURA计划或FLAURA研究的EGFRm NSCLC患者中的长期耐受性

2025-01-010
PRE
Long-read sequencing of an advanced cancer cohort resolves rearrangements, unravels haplotypes, and reveals methylation landscapes
2024-11-011
OAAI
Application of tissue and liquid-based next generation sequencing (NGS) for comprehensive genomic profiling: Evaluating the clinical value of ctDNA technology in treatment decision making

组织及液体样本下一代测序(NGS)在全面基因组分型中的应用:评估ctDNA技术在治疗决策中的临床价值

2024-09-010
PRE
Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers
2024-05-163
OAAI